James J. Walker — Endo Lab

article 2001

International Journal of Gynecology & Obstetrics ·doi:10.1016/s0020-7292(01)00461-1

article 2001

Focus for the future: tackling the ‘pelvic pain’ problem in gynecologic practice — an interactive session

International Journal of Gynecology & Obstetrics ·doi:10.1016/s0020-7292(01)00462-3

OBJECTIVE: The clinical management of women with chronic pelvic pain (CPP) and endometriosis involves important issues that exist at the interface between these two conditions. METHODS: To address these issues, an interactive session was co…

article 2001

Moving toward a new therapeutic model for chronic pelvic pain: a summary

·doi:10.1016/s0020-7292(01)00463-5

article 2001

Re‐defining the focus in the management of chronic pelvic pain

International Journal of Gynecology & Obstetrics ·doi:10.1016/s0020-7292(01)00457-x

article 1999

GnRH analogue in everyday gynecology, Is it possible to rationalize its use?

·doi:10.1034/j.1600-0412.1999.780413.x

BACKGROUND: The study was an audit of patients who attended the Menstrual Disorders Clinic at Glasgow Royal Infirmary over a five year period, and received gonadotrophin-releasing hormone analog (GnRHa). We aimed to identify the clinical in…

rct 1999

Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists

American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(99)70140-7

OBJECTIVES: Our purpose was to assess the changes in uterine volume and uterine artery pulsatility index in response to gonadotropin-releasing hormone agonist treatment in women undergoing hysterectomy for nonfibroid-related uterine bleedin…

review 1998

How should we approach the management of pelvic pain?

Gynecologic and obstetric investigation ·doi:10.1159/000052846

Pelvic pain is a common debilitating condition. Most investigations are invasive, expensive and usually negative. Although a positive diagnosis of endometriosis justifies a recognized treatment programme, the majority of women with negative…

article 1991

A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia

·doi:10.1136/pgmj.67.791.833

This randomized open study compared the efficacy and safety of norethisterone, 5 mg three times a day from day 19 to 26, and danazol, 200 mg daily, in the treatment of dysfunctional uterine bleeding presenting as menorrhagia. Clinical crite…